SCL Science Past Earnings Performance

Past criteria checks 0/6

SCL Science's earnings have been declining at an average annual rate of -15.9%, while the Medical Equipment industry saw earnings growing at 11.2% annually. Revenues have been growing at an average rate of 2.1% per year.

Key information

-15.9%

Earnings growth rate

-10.9%

EPS growth rate

Medical Equipment Industry Growth22.7%
Revenue growth rate2.1%
Return on equity-26.6%
Net Margin-380.2%
Last Earnings Update31 Dec 2023

Recent past performance updates

No updates

Recent updates

Is InnoTherapy (KOSDAQ:246960) Using Debt In A Risky Way?

Apr 01
Is InnoTherapy (KOSDAQ:246960) Using Debt In A Risky Way?

InnoTherapy (KOSDAQ:246960) Has Debt But No Earnings; Should You Worry?

Dec 15
InnoTherapy (KOSDAQ:246960) Has Debt But No Earnings; Should You Worry?

Revenue & Expenses Breakdown
Beta

How SCL Science makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

KOSDAQ:A246960 Revenue, expenses and earnings (KRW Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 231,322-5,0262,6621,235
30 Sep 23809-5,4502,4051,259
30 Jun 23625-7,7202,7251,314
31 Mar 23483-5,5842,9351,253
31 Dec 22370-5,9723,0371,338
30 Sep 22349-7,0873,5631,358
30 Jun 22340-5,7523,4331,243
31 Mar 22425-5,4713,2461,500
31 Dec 21507-5,0293,0921,423
30 Sep 21539-3,0112,9461,447
30 Jun 21627-3,5492,7411,524
31 Mar 21612-3,2512,7121,246
31 Dec 20596-3,0472,6371,239
30 Sep 20657-3,7812,5991,178
30 Jun 20622-3,5292,4611,012
31 Mar 20668-3,5492,540979
31 Dec 19693-3,9893,169958
30 Sep 19711-3,6803,022964
30 Jun 19695-3,6033,065967
31 Mar 19578-3,3792,670973
31 Dec 18512-2,5741,908816
30 Sep 18382-2,9691,902675
30 Jun 18284-2,8381,844459
31 Mar 18257-2,8871,826498
31 Dec 17203-3,0121,724652
31 Dec 16101-7781,303334
31 Dec 1514-4,8231,012264
31 Dec 1442-79425111

Quality Earnings: A246960 is currently unprofitable.

Growing Profit Margin: A246960 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: A246960 is unprofitable, and losses have increased over the past 5 years at a rate of 15.9% per year.

Accelerating Growth: Unable to compare A246960's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: A246960 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (8.8%).


Return on Equity

High ROE: A246960 has a negative Return on Equity (-26.59%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.